Synapse Peptides
Semax / 10mg
Lot SPSEMX001 · 99.67% purity · Tested 2026-09-23
Overview
Synthetic ACTH (4-10) analogue. Reference compound for studies of neurotrophic and nootropic pathways.
Compound data
- Lot
- SPSEMX001
- Purity
- 99.67%
- Assay method
- HPLC-MS
- Test date
- 2026-09-23
- CAS number
- 80714-61-0
- Molecular weight
- 813.9 g/mol
- Manufacture
- EU GMP
Description
About Semax
Semax is a synthetic analogue of the ACTH (4-10) fragment, studied as a reference compound in neuropeptide and cognitive research.
Documented research applications
Used in vitro and in animal model studies investigating:
- BDNF and NGF expression
- Neuroprotection and ischemia models
- Attention and memory pathways
Origin and quality
Synthesized by solid-phase peptide synthesis. Lyophilized powder. Every lot is independently assayed for identity and purity by a third-party laboratory; see COA.
Handling
Store at minus 20C. Reconstitute per laboratory protocol.
For research use only. Not for human consumption. Not approved by Health Canada or the FDA for therapeutic use.
Research use
All products are supplied for laboratory and research use only and are not for human consumption, diagnostic, or therapeutic use.
Related products
-
Select options This product has multiple variants. The options may be chosen on the product page
-
LOT SPPT14001
Select options This product has multiple variants. The options may be chosen on the product page
-
LOT SPMT2001
Select options This product has multiple variants. The options may be chosen on the product page
-
Select options This product has multiple variants. The options may be chosen on the product page
